Vjneurology

3:56

IkT-148009 as a potential disease-modifying therapy in Parkinson's disease VJNeurology 483 1,611 2 года назад

3:48

Overlap between functional neurological disorders and PD VJNeurology 2K 5,332 2 года назад

1:52

Microbiota-targeting agents for Parkinson’s disease VJNeurology 123 410 3 года назад

2:40

Real-world application of the MSDA test to monitor disease activity in MS VJNeurology 18 61 7 месяцев назад

2:52

Optimizing VNS intensity for stroke recovery VJNeurology 66 221 3 года назад

3:14

Challenges with cenobamate use in focal epilepsy VJNeurology 47 155 1 год назад

2:02

Revisiting the concept of autoimmune epilepsy VJNeurology 166 554 3 года назад

4:12

Biomarkers for the diagnosis of Parkinson’s disease VJNeurology 39 129 5 месяцев назад

2:28

Tolebrutinib reduces new MRI lesions in highly active relapsing MS VJNeurology 142 473 3 года назад

1:28

Options for treating rare and complex epilepsies VJNeurology 16 54 2 месяца назад

1:43

Prioritizing research into the cognitive outcomes of stroke VJNeurology 4 13 6 месяцев назад

1:31

Novel therapeutics to repair damage in multiple sclerosis VJNeurology 17 55 2 месяца назад

1:33

Moral considerations when inducing seizures in patients with epilepsy VJNeurology 43 144 2 года назад

2:40

Impact of image harmonization on MS imaging practice VJNeurology 18 60 1 год назад

2:22

Improving global outcomes in epilepsy VJNeurology 15 51 3 года назад

3:15

Potential treatment targets for migraine VJNeurology 20 66 4 месяца назад

2:45

The importance of disease modifying therapy in iRBD VJNeurology 18 60 2 года назад

5:21

How is amyloid beta cleared from the brain and why does this system fail? VJNeurology 2K 5,311 2 года назад

Vjneurology. Смотреть видео: IkT 148009 As A Potential Disease Modifying Therapy In Parkinson S Disease, Overlap Between Functional Neurological Disorders And PD, Microbiota Targeting Agents For Parkinson S Disease, Real World Application Of The MSDA Test To Monitor Disease Activity In MS.